Clinical Trial Detail

NCT ID NCT03674827
Title A Study To Evaluate Escalating Doses of A Vaccine-Based Immunotherapy Regimen For NSCLC and TNBC
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications

triple-receptor negative breast cancer

lung non-small cell carcinoma

Therapies

PF-06936308

Age Groups: senior adult

No variant requirements are available.